# Screening Anti-Fungal Exposure in Intensive Care Units

> **NCT03136926** · — · UNKNOWN · sponsor: **The University of Queensland** · enrollment: 150 (estimated)

## Conditions studied

- Antifungal Agents

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03136926
- **Lead sponsor:** The University of Queensland
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-01
- **Primary completion:** 2018-09
- **Final completion:** 2018-12
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2018-06-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03136926

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03136926, "Screening Anti-Fungal Exposure in Intensive Care Units". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03136926. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*